This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
TLG Andersson , J Matz , GAA Ferns & EE Änggård (1994) Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 111, 39–45.
E Aratri , SE Spycher , I Breyer & A Azzi (1999) Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Letters 447, 91–94.
PA Baeuerle & D Baltimore (1996) NF-kappa B: ten years after. Cell 87,13-20.
PA Baeuerle & T Henkel (1996) Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12, 141–179.
CS Baker , RJ Hall , TJ Evans , A Pomerance , J Maclouf , C Creminon , MH Yacoub & JM Polak (1999) Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arteriosclerosis Thrombosis and Vascular Biology 19, 646–655.
C Ben Hamida , N Doerflinger , S Belal , C Linder , L Reutenauer , C Dib et al. (1993) Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nature Genetics 5, 195–200.
DH Blatt , SW Leonard & MG Traber (2001) Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 17, 799–805.
RH Böger , SM Bode-Böger , L Phivthong-ngam , RP Brandes , E Schwedhelm , A Mügge , D Böhme , D Tsikas & JC Frölich (1998) Dietary l-arginine and a-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 141, 31–44.
D Boscoboinik , A Szewczyk & A Azzi (1991a) Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Archives of Biochemistry and Biophysics 286, 264–269.
K Brand , S Page , G Rogler , A Bartsch , R Brandl , R Knuechel , M Page , C Kaltschmidt , PA Baeuerle & D Neumeier (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Journal of Clinical Investigation 97, 1715–1722.
K Brand , S Page , AK Walli , D Neumeier & PA Baeuerle (1997) Role of nuclear factor-kappa B in atherogenesis. Experimental Physiology 82, 297–304.
R Busse & I Fleming (1995) Regulation and functional consequences of endothelial nitric oxide formation. Annals of Medicine 27, 331–340.
LE Cardonna-Sanclemente & GVR Born (1995) Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rats. British Journal of Pharmacology 114, 1490–1494.
GL Catignani & JG Bieri (1977) Rat liver alpha-tocopherol binding protein. Biochimica et Biophysica Acta 497, 349–357
DS Celermajer , KE Sorensen , D Georgakopoulos , C Bull , O Thomas , J Robinson & JE Deanfield (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88, 2149–2155.
CJ Chen , HS Huang , SB Lin & WC Chang (2000) Regulation of cyclooxygenase and 12-lipoxygenase catalysis by phospholipid hydroperoxide glutathione peroxidase in A431 cells. Prostaglandins Leukotrienes and Essential Fatty Acids 62, 261–268.
S Clement , A Tasinato , D Boscoboinik & A Azzi (1997) The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation. European Journal of Biochemistry 246, 745–749.
T Collins & MI Cybulski (2001) NF-kB: pivotal mediator or innocent bystander in atherogenesis. Journal of Clinical Investigation 107, 255–264.
JP Cooke , AH Singer , P Tsao , P Zera , RA Rowan & ME Bilingam (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. Journal of Clinical Investigation 90, 1168–1172.
MI Cybulski & MA Gimbrone (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791.
RK Davda , LJ Chandler & NJ Guzman (1994) Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. European Journal of Pharmacology 266, 237–244.
R De Caerina , P Libby , HB Peng , VJ Thannickal , TB Rajavashisth , MAJ Gimbrone , WS Shin & JK Liao (1995) Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. Journal of Clinical Investigation 96, 60–68.
JC De Graaf , JD Banga , S Moncado , RM Palmer , PG de Groot & JJ Sixma (1992) Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85, 2284–2290.
S Devaraj , D Li & I Jialal (1996) The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. Journal of Clinical Investigation 98, 756–763.
AK Dutta-Roy (1999) Molecular mechanism of cellular uptake and intracellular translocation of alpha-tocopherol: role of tocopherol-binding proteins. Food and Chemical Toxicology 37, 967–971.
H Fechner , M Schlame , F Guthmann , PA Stevens & B Rustow (1998) Alpha- and delta-tocopherol induce expression of hepatic alpha-tocopherol-transfer-protein mRNA. Biochemical Journal 331, 577–581.
A Fischer , J Pallauf , K Gohil , SU Weber , L Packer & G Rimbach (2001) Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochemical and Biophysical Research Communications 285, 470–475.
JE Freedman , JH Farhat , J Loscalzo & JF Jr Keaney (1996) Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94, 2434–2440.
J Freubis , TE Carew & W Palinski (1995) Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 117, 217–224.
UC Garg & A Hassid (1989) Nitric oxide generation vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 83, 1774–1777.
B Halliwell (1996) Antioxidants in human health and disease. Annual Review of Nutrition 16, 33–50.
K Hehenberger & A Hansson (1997) High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochemistry and Function 15, 197–201.
E Herrera & C Barbas (2001) Vitamin E: action, metabolism and perspectives. Journal of Physiology and Biochemistry 57, 43–56.
A Hosomi , M Arita , Y Sato , C Kiyose , T Ueda , O Igarashi , H Arai & K Inoue (1997) Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Letters 409, 105–108.
KU Ingold , AC Webb , D Witter , GW Burton , TA Metcalfe & DP Muller (1987) Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Archives of Biochemistry and Biophysics 259, 224–225.
Q Jiang , I Elson-Schwab , C Courtemanche & BN Ames (2000) Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proceedings of the National Academy of Sciences USA 97, 11494–11499.
VE Kagan & YY Tyurina (1998) Recycling and redox cycling of phenolic antioxidants. Annals of the New York Academy of Sciences 854, 425–434.
T Kanno , T Utsumi , H Kobuchi , Y Takehara , J Akiyama , T Yoshioka , AA Horton & K Utsumi (1995) Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radical Research 22, 431–440.
JF Jr Keaney , JM Gaziano , A Xu , B Frei , J Curran-Celtano , GT Shwaery , J Loscalzo & JA Vita (1994) Low dose a-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. Journal of Clinical Investigation 93, 844–851.
L Lagrost , C Desrumaux , D Masson , V Deckert & P Gambert (1998) Structure and function of the plasma phospholipid transfer protein. Current Opinion in Lipidology 9, 203–209.
CPM Leeson , PH Whincup , DG Cook , AE Donald , O Papacosta , A Lucas & JE Deanfield (1997) Flow mediated dilation in 9- to 11-year old children - the influence of intrauterine and childhood factors. Circulation 96, 2233–2238.
D Li , T Saldeen , F Romeo & JL Metha (2001) Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implication in therapy with vitamin E. Journal of Cardiovascular Pharmacology and Therapy 6, 155–161.
F Liao , A Andalibi , FC deBeer , AM Fogelman & AJ Lusis (1993) Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. Journal of Clinical Investigation 91, 2572–2579.
JR Matthews , CH Botting , M Panico , HR Morris & RT Hay (1996) Inhibition of NF-kappa B DNA binding by nitric oxide. Nucleic Acids Research 24, 2236–2242.
T Nakamura , M Goto , A Matsumoto & I Tanaka (1998) Inhibition of NF-kappa B transcriptional activity by alpha-tocopheryl succinate. Biofactors 7, 21–30.
K Naruse , K Shimizu , M Muramatsu , Y Toki , Y Miyazaki , K Okumura , H Hashimoto & T Ito (1994) Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arteriosclerosis and Thrombosis 14, 746–752.
NK Özer & A Azzi (2000) Effect of vitamin E on the development of atherosclerosis. Toxicology 148, 179–185.
JA Panza , CE Garcia , CM Kilcoyne , AA Quyyumi & 3rd Cannon RO (1995) Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91, 1732–1738.
RP Patel , AL Levonen , JH Crawford & VM Darley-Usma (2000) Mechanisms of the pro- and antioxidant actions of nitric oxide in atherosclerosis. Cardiovascular Research 47, 465–474.
R Ricciarelli , A Tasinato , S Clement , NK Ozer , D Boscoboinik & A Azzi (1998) alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochemical Journal 334, 243–249.
R Ricciarelli , JM Zingg & A Azzi (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102, 82–87.
G Rimbach , G Valacchi , R Canali & F Virgili (2000) Macrophages stimulated with IFN-gamma activate NF-kB and induce MCP-1 gene expression in primary human endothelial cells. Molecular and Cell Biology Research Communications 3, 238–242.
GM Rubanyi (1993) The role of endothelium in cardiovascular homeostasis and diseases. Journal of Cardiovascular Pharmacology 22, 1–14.
C Saliou , G Valacchi & G Rimbach (2001) Assessing bioflavonoids as regulators of NF-kB acitivity and gene expression in mammalian cells. Methods in Enzymology 335, 380–387.
DC Schwenke & SR Behr (1998) Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circulation Research 83, 366–377.
E Serbinova , V Kagan , D Han & L Packer (1991) Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radicals in Biology and Medicine 10, 263–275.
AL Stewart-Lee , LA Forster , J Nouroz-Zadeh , GAA Ferns & EE Änggård (1994) Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arteriosclerosis and Thrombosis 14, 494–499.
A Stocker , S Zimmer , SE Spycher & A Azzi (1999) Identification of a novel cytosolic tocopherol-binding protein: structure, specificity, and tissue distribution. IUBMB Life 48, 49–55.
ES Stroes , HA Koomans , TW de Bruin & TJ Rabelink (1995) Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346, 467–471.
YJ Suzuki & L Packer (1993) Inhibition of NF-kappa B activation by vitamin E derivatives. Biochemical and Biophysical Research Communications 193, 277–283.
YJ Suzuki , M Tsuchiya , SR Wassall , YM Choo , G Govil , VE Kagan & L Packer (1993) Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32, 10692–10699.
H Tada , H Ishii & S Isogai (1997) Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46, 779–784.
Y Terasawa , Z Ladha , SW Leonard , JD Morrow , D Newland , D Sanan , L Packer , MG Traber & RV Jr Farese (2000) Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proceedings of the National Academy of Sciences USA 97, 13830–13834.
J Thiery , D Teupser , AK Walli , B Ivandic , K Nebendahl , O Stein , Y Stein & D Seidel (1996) Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis 121, 63–73.
MG Traber & HJ Kayden (1989) Alpha-tocopherol as compared with gamma-tocopherol is preferentially secreted in human lipoproteins. Annals of the New York Academy of Sciences 570, 95–108.
MG Traber , RJ Sokol , GW Burton , KU Ingold , AM Papas , JE Huffaker & HJ Kayden (1990) Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. Journal of Clinical Investigation 85, 397–407.
CM Watanabe , S Wolffram , P Ader , G Rimbach , L Packer , JJ Maguire , PG Schultz & K Gohil (2001) The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proceedings of the National Academy of Sciences USA 98, 6577–6580.
FK Welty , AH Lichtenstein , PH Barrett , JL Jenner , GG Dolnikowski & EJ Schaefer (2000) Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Arteriosclerosis Thrombosis and Vascular Biology 20, 1807–1810.
RJ Williams , JM Motteram , CH Sharp & PJ Gallagher (1992) Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94, 153–159.
SB Williams , JA Cusco , MA Roddy , MT Johnstone & MA Creager (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 27, 567–574.
J Yamauchi , T Iwamoto , S Kida , S Masushige , K Yamada & T Esashi (2001) Tocopherol-associated protein is a ligand-dependent transcriptional activator. Biochemical and Biophysical Research Communications 285, 295–299.
N Yoshida , H Manabe , Y Terasawa , H Nishimura , F Enjo , H Nishino & T Yoshikawa (2000) Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors 13, 279–288.
D Zapolska-Downar , A Zapolski-Downar , M Markiewski , A Ciechanowicz , M Kaczmarczyk & M Naruszewicz (2000) Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochemical and Biophysical Research Communications 274, 609–615.
S Zimmer , A Stocker , MN Sarbolouki , SE Spycher , J Sassoon & A Azzi (2000) A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. Journal of Biological Chemistry 275, 25672–25680.